XML 35 R22.htm IDEA: XBRL DOCUMENT v3.25.2

Note 16 - Non-controlling Interests

3 Months Ended

Aug. 31, 2025

Notes to Financial Statements

Noncontrolling Interest Disclosure [Text Block]

Note 16. Non-controlling interests

The following are majority-owned subsidiaries of the Company and the percentage of ownership interest maintained by the Company is set forth in the parenthetical: Aphria Diamond (51%), and Colcanna S.A.S. (90%).

The following table provides a summary of certain balance sheet information before intercompany eliminations relating to the above-referenced majority-owned subsidiaries of the Company in which there was a non-controlling interest as of August 31, 2025:

		Aphria				ColCanna				August 31,
		Diamond				S.A.S.				2025
Current assets		$	90,684			$	5			$	90,689
Non-current assets			112,250				3,485				115,735
Current liabilities			(128,471	)			(7,036	)			(135,507	)
Non-current liabilities			(31,408	)			(1,442	)			(32,850	)
Net assets		$	43,055			$	(4,988	)		$	38,067

The following table provides a summary of certain balance sheet information before intercompany eliminations relating to the above-referenced majority-owned subsidiaries of the Company in which there was a non-controlling interest as of May 31, 2025:

		SH				CC Pharma				Aphria				ColCanna				May 31,
		Acquisition				Nordic ApS				Diamond				S.A.S.				2025
Current assets		$	—			$	—			$	83,390			$	20			$	83,410
Non-current assets			—				—				114,677				3,348				118,025
Current liabilities			—				—				(126,986	)			(6,953	)			(133,939	)
Non-current liabilities			—				—				(31,720	)			(1,442	)			(33,162	)
Net assets		$	—			$	—			$	39,361			$	(5,027	)		$	34,334

The following table provides a summary of certain income statement information before intercompany eliminations relating to the above referenced majority-owned subsidiaries of the Company in which there was a non-controlling interest for the three months ended August 31, 2025:

		Aphria				ColCanna				August 31,
		Diamond				S.A.S.				2025
Revenue		$	18,102			$	—			$	18,102
Total expenses			13,497				(186	)			13,311
Net (loss) income			4,605				186				4,791
Other comprehensive (loss) income			(911	)			(147	)			(1,058	)
Net comprehensive (loss) income		$	3,694			$	39			$	3,733
Non-controlling interest %			49	%			10	%		NA
Comprehensive (loss) income attributable to NCI			1,810				4				1,814
Net comprehensive (loss) income attributable to NCI		$	1,810			$	4			$	1,814

The following table provides a summary of certain income statement information before intercompany eliminations relating to the above referenced majority-owned subsidiaries of the Company in which there was a non-controlling interest for the three months ended August 31, 2024:

		SH				CC Pharma				Aphria				ColCanna				August 31,
		Acquisition				Nordic ApS				Diamond				S.A.S.				2024
Revenue		$	—			$	—			$	18,558			$	—			$	18,558
Total expenses			—				5				9,216				630				9,851
Net (loss) income			—				(5	)			9,342				(630	)			8,707
Other comprehensive (loss) income			—				(1	)			1,041				277				1,317
Net comprehensive (loss) income		$	—			$	(6	)		$	10,383			$	(353	)		$	10,024
Non-controlling interest %			32	%			25	%			49	%			10	%		NA
Comprehensive (loss) income attributable to NCI			—				(2	)			5,088				(35	)			5,051
Net comprehensive (loss) income attributable to NCI		$	—			$	(2	)		$	5,088			$	(35	)		$	5,051

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureTextBlockAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The entire disclosure for noncontrolling interest in consolidated subsidiaries, which could include the name of the subsidiary, the ownership percentage held by the parent, the ownership percentage held by the noncontrolling owners, the amount of the noncontrolling interest, the location of this amount on the balance sheet (when not reported separately), an explanation of the increase or decrease in the amount of the noncontrolling interest, the noncontrolling interest share of the net Income or Loss of the subsidiary, the location of this amount on the income statement (when not reported separately), the nature of the noncontrolling interest such as background information and terms, the amount of the noncontrolling interest represented by preferred stock, a description of the preferred stock, and the dividend requirements of the preferred stock.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 810
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/810/tableOfContent

+ Details

Name:	us-gaap_MinorityInterestDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration